Evidence map›Paper›PMID 38983867›Full record

ArticleJournal of virus eradication2024

Community dialogue to enhance understanding of beliefs, behaviours and barriers to care for people living with liver disease and HBV infection in KwaZulu Natal, South Africa.

Busangani Ngwenya, Motswedi Anderson, Nondumiso Mpanza, Welcome Mbokazi, Luthando Zuma, Thandeka Khoza, Gloria Sukali, Elizabeth Waddilove, Marion Delphin, Collins Iwuji and 7 more

Abstract read
In one paragraph

Article in Journal of virus eradication, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Busangani NgwenyaAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Motswedi AndersonAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Nondumiso MpanzaAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Welcome MbokaziAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Luthando ZumaAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Thandeka KhozaAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Gloria SukaliAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Elizabeth WaddiloveThe Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Marion DelphinThe Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Collins IwujiAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Ngcebo MhlongoAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Nomathamsanqa MajoziAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Janet SeeleyAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Janine UptonAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Guy HarlingAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Philippa C MatthewsThe Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Anita EdwardsAfrica Health Research Institute, KwaZulu-Natal, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The World Health Organisation (WHO) has set targets for the elimination of Hepatitis B virus (HBV), which include preventing new infections and reducing deaths. We explored beliefs, behaviours and barriers to diagnosis, prevention and treatment for people living with HBV infection (PLWHB) and those with liver disease in a rural South African population in KwaZulu-Natal, to gather information to inform research and support the development of improved clinical and public health services. Methods: Using an interdisciplinary approach (combining public engagement, social science, clinical and laboratory team members) we conducted a community dialogue with members of the Africa Health Research Institute (AHRI) Community Advisory Board (CAB). Notes from the discussions were used to write up an account from which themes were identified during a team debrief session for data analysis. Results: There was a lack of knowledge and awareness of HBV infection and transmission and prevention amongst CAB members, also reported among community members and healthcare workers. The participants recognised liver disease symptoms. Perceived causes of liver disease reported by the CAB were alcohol and non-adherence to HIV treatment. Barriers to care included stigma, poverty, and delays in referrals for HBV diagnosis and management. Conclusion: Understanding barriers to care is important to shape future services for diagnosis, treatment and prevention of HBV and liver disease which are accessible, affordable and acceptable to the local population. Education, awareness and advocacy for improved liver health care pathways are required to make them effective for local communities.

Indexed as

Community engagementHealth literacyHepatitis B virusHIVLiver diseasePublic engagementSouth AfricaStigma

Identifiers

PMID38983867
PMCPMC11228947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.